Global Dynamics Technology

The NTD 1000, trigger point therapy device is an effective pain management system based on proprietary Ischemic Compression Technology (ICT). The purpose of the invention is to provide an apparatus for controlled trigger point therapy, providing the new ischemic compression (IC) for chronic myofascial pain to the general public and medical healthcare professionals. Global Dynamics…

Read More

MEG Cura

MEG Cura is a patients compilance and reporting solution for physical therapists that improves treatment outcomes and decreases administrative costs. MEG Cura Team: Maryam Alkhaldi Meshal Alhathal  

Read More

Energizing Solutions

We will develop an evidence-based diet and physical activity assessment and intervention tool to facilitate compliance with prescribed regimens (i.e., diabetes, cardiovascular disease, weight loss). Energizing Solutions Team: Jeannette Beasley, PhD, MPH, RDN Joshua Chodosh, MD

Read More

Innovene, Inc.

Innovene has designed a new class of medications from safe plant-derived components; TriCurin will target the unmet medical need of treating patients with oncogenic human papillomavirus infections. Innovene Team: Mario Castellanos, MD, Co-Founder and President Alia Kozlova

Read More

Seeq

Seeq aims to advance precision medicine by creating a billion-person scale genomics dataset and making genome exploration approachable and inexpensive for consumers and researchers. Team: Kaja Wasik

Read More

TermAffirm

TermAffirm is an ultrasound-based diagnostic which identifies women at high risk for cervical insufficiency in pregnancy, and an associated patient-specific cervical pessary. TermAffirm Team: Andrew Westervelt, Founder

Read More

Bioharmony Therapy

Bioharmony Therapeutics is an early-stage biotech startup focused on the development of first-in-class antimicrobials that target infections caused by Gram-negative bacteria. Bioharmony Theraputics Team: Chandrabali Ghose-Paul, Founder and CEO

Read More

CatheCare

CatheCare’s CASS device uses ultraviolet light to prevent the deadly catheter-related infection.   Team: Aonnicha Burapachaisr – CEO Chanond Sophonpanich – COO

Read More

CalRegen, Inc.

CalRegen, Inc is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.…

Read More